Phreesia, INC Form 4 insider transactions

Phreesia, Inc. Director Lainie Goldstein was granted 6,700 Restricted Stock Units (RSUs) valued at $27.61 per share, increasing her beneficial ownership to 48,555 shares.

Phreesia, Inc. Director Michael Weintraub was granted 6,700 Restricted Stock Units (RSUs) valued at $27.61 per share, increasing his beneficial ownership in the company.

Phreesia, Inc. Director Gillian Munson was granted 6,700 Restricted Stock Units (RSUs) valued at $27.61 per share, which will vest by June 2026 or the next annual meeting.

Phreesia, Inc. Director Ramin Sayar was granted 6,700 Restricted Stock Units (RSUs) valued at $27.61 per share, increasing his beneficial ownership to 33,435 shares.

Phreesia, Inc. Director Edward L. Cahill was granted 6,700 Restricted Stock Units (RSUs) valued at $27.61 per share, increasing his beneficial ownership to 62,973 shares.

Phreesia, Inc. Director Lisa Egbuonu-Davis reported the acquisition of 6,700 Restricted Stock Units and the sale of 2,802 shares of common stock under a pre-arranged 10b5-1 trading plan.

Phreesia, Inc. SVP, Network Solutions, David Linetsky, sold 109 shares of common stock in non-discretionary transactions to satisfy tax withholding obligations related to restricted stock unit settlements.

Phreesia, Inc. Director Michael Weintraub executed pre-arranged transactions in early June 2025, exercising stock options and subsequently selling 10,000 shares of common stock at market prices significantly above his exercise cost.

Phreesia's Principal Accounting Officer, Yvonne Hui, sold 582 shares of common stock for $28 per share on June 10, 2025, as part of a pre-arranged 10b5-1 trading plan.

Yvonne Hui, Principal Accounting Officer of Phreesia Inc., reports the acquisition of 9,000 shares of common stock and disposal of shares on May 15, 2025, along with holding 31,592 shares following the transaction.

David Linetsky, SVP of Life Sciences at Phreesia, Inc., files a Form 4 to correct previously unreported transactions and adjustments to the beneficial ownership of common stock held by his spouse.

Director Gillian Munson acquired 400 shares of Phreesia Inc. common stock at $24.96 per share on April 30, 2025, through deferred stock units.

Director Lainie Goldstein acquired 400 shares of Phreesia, Inc. common stock at $24.96 per share on April 30, 2025, through the receipt of deferred stock units (DSUs) in lieu of an annual cash retainer.

Director Edward Cahill acquired 400 shares of Phreesia, Inc. common stock at $24.96 per share on April 30, 2025, through deferred stock units (DSUs) in lieu of an annual cash retainer.

David Linetsky, SVP of Life Sciences at Phreesia, Inc., reported the sale of 260 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Yvonne Hui, Principal Accounting Officer of Phreesia Inc., reports the sale of company stock to cover tax obligations and pursuant to a pre-arranged trading plan.

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold shares of common stock to cover tax obligations and pursuant to a pre-arranged Rule 10b5-1 trading plan.

Amy Beth VanDuyn, SVP of Human Resources at Phreesia Inc., sold 624 shares of common stock on April 16, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.

Chief Operating Officer of Phreesia Inc., Evan Roberts, disposed of 1,845 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Chaim Indig, CEO of Phreesia, Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Yvonne Hui, Principal Accounting Officer of Phreesia Inc., reported the sale of company stock on April 15 and 16, 2025, according to a Form 4 filing with the SEC.

Allison C. Hoffman, General Counsel & Secretary of Phreesia Inc., reports the sale of 1,213 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Balaji Gandhi, CFO of Phreesia, Inc., sold 864 shares of common stock on April 16, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Phreesia's CEO, Chaim Indig, disposed of shares to cover tax withholding obligations related to the settlement of restricted stock units.

Amy Beth VanDuyn, SVP of Human Resources at Phreesia Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Evan Roberts, Chief Operating Officer of Phreesia Inc., sold shares of common stock on April 8, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.

Yvonne Hui, Principal Accounting Officer of Phreesia Inc., sold shares of common stock to cover tax obligations and under a pre-arranged 10b5-1 trading plan.

Allison C. Hoffman, General Counsel & Secretary of Phreesia Inc., sold shares of common stock to cover tax obligations and under a pre-arranged 10b5-1 trading plan.

Balaji Gandhi, CFO of Phreesia, Inc., sold shares of common stock on April 8, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.